109 related articles for article (PubMed ID: 17046253)
1. Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): the homovanillyl moiety.
Appendino G; Ech-Chahad A; Minassi A; Bacchiega S; De Petrocellis L; Di Marzo V
Bioorg Med Chem Lett; 2007 Jan; 17(1):132-5. PubMed ID: 17046253
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): The side chain benzylic methylene.
Appendino G; Ech-Chahad A; Minassi A; De Petrocellis L; Di Marzo V
Bioorg Med Chem Lett; 2010 Jan; 20(1):97-9. PubMed ID: 19951840
[TBL] [Abstract][Full Text] [Related]
3. Similarities and differences in the structure-activity relationships of capsaicin and resiniferatoxin analogues.
Walpole CS; Bevan S; Bloomfield G; Breckenridge R; James IF; Ritchie T; Szallasi A; Winter J; Wrigglesworth R
J Med Chem; 1996 Jul; 39(15):2939-52. PubMed ID: 8709128
[TBL] [Abstract][Full Text] [Related]
4. Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists.
Choi HK; Choi S; Lee Y; Kang DW; Ryu H; Maeng HJ; Chung SJ; Pavlyukovets VA; Pearce LV; Toth A; Tran R; Wang Y; Morgan MA; Blumberg PM; Lee J
Bioorg Med Chem; 2009 Jan; 17(2):690-8. PubMed ID: 19135377
[TBL] [Abstract][Full Text] [Related]
5. A high concentration of resiniferatoxin inhibits ion channel function in clonal neuroendocrine cells.
Sugimoto K; Kissin I; Strichartz G
Anesth Analg; 2008 Jul; 107(1):318-24. PubMed ID: 18635503
[TBL] [Abstract][Full Text] [Related]
6. Functional mapping of the transient receptor potential vanilloid 1 intracellular binding site.
Johnson DM; Garrett EM; Rutter R; Bonnert TP; Gao YD; Middleton RE; Sutton KG
Mol Pharmacol; 2006 Sep; 70(3):1005-12. PubMed ID: 16763090
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.
Kim MS; Ki Y; Ahn SY; Yoon S; Kim SE; Park HG; Sun W; Son K; Cui M; Choi S; Pearce LV; Esch TE; Deandrea-Lazarus IA; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2014 Jan; 24(1):382-5. PubMed ID: 24321344
[TBL] [Abstract][Full Text] [Related]
8. Fatty acyl amides of endogenous tetrahydroisoquinolines are active at the recombinant human TRPV1 receptor.
O'Dell DK; Rimmerman N; Pickens SR; Walker JM
Bioorg Med Chem; 2007 Sep; 15(18):6164-9. PubMed ID: 17616464
[TBL] [Abstract][Full Text] [Related]
9. The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination.
Appendino G; Daddario N; Minassi A; Moriello AS; De Petrocellis L; Di Marzo V
J Med Chem; 2005 Jul; 48(14):4663-9. PubMed ID: 16000002
[TBL] [Abstract][Full Text] [Related]
10. The carbonate analogues of 5'-halogenated resiniferatoxin as TRPV1 ligands.
Lim KS; Lee H; Kim SE; Ha TH; Ann J; Son K; Choi S; Sun W; Pearce LV; DeAndrea-Lazarus IA; Blumberg PM; Lee J
Eur J Med Chem; 2013 Oct; 68():233-43. PubMed ID: 23981530
[TBL] [Abstract][Full Text] [Related]
11. Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism.
Ziglioli F; Frattini A; Maestroni U; Dinale F; Ciufifeda M; Cortellini P
Acta Biomed; 2009 Apr; 80(1):13-20. PubMed ID: 19705615
[TBL] [Abstract][Full Text] [Related]
12. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death.
Athanasiou A; Smith PA; Vakilpour S; Kumaran NM; Turner AE; Bagiokou D; Layfield R; Ray DE; Westwell AD; Alexander SP; Kendall DA; Lobo DN; Watson SA; Lophatanon A; Muir KA; Guo DA; Bates TE
Biochem Biophys Res Commun; 2007 Mar; 354(1):50-5. PubMed ID: 17214968
[TBL] [Abstract][Full Text] [Related]
13. Perineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats.
Kissin I; Freitas CF; Bradley EL
Anesth Analg; 2007 May; 104(5):1210-6, tables of contents. PubMed ID: 17456676
[TBL] [Abstract][Full Text] [Related]
14. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord.
Zhou HY; Chen SR; Chen H; Pan HL
J Pharmacol Exp Ther; 2008 Nov; 327(2):375-82. PubMed ID: 18669865
[TBL] [Abstract][Full Text] [Related]
15. Preventive effect of TRPV1 agonists capsaicin and resiniferatoxin on ischemia/reperfusion-induced renal injury in rats.
Ueda K; Tsuji F; Hirata T; Takaoka M; Matsumura Y
J Cardiovasc Pharmacol; 2008 May; 51(5):513-20. PubMed ID: 18460982
[TBL] [Abstract][Full Text] [Related]
16. TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons.
Xing J; Li J
J Neurophysiol; 2007 Jan; 97(1):503-11. PubMed ID: 17065246
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice.
Fukushima A; Fujii M; Ono H
J Vis Exp; 2020 Sep; (163):. PubMed ID: 32955494
[TBL] [Abstract][Full Text] [Related]
18. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1.
Marincsák R; Tóth BI; Czifra G; Szabó T; Kovács L; Bíró T
Anesth Analg; 2008 Jun; 106(6):1890-6. PubMed ID: 18499628
[TBL] [Abstract][Full Text] [Related]
19. Topical acetone treatment induces neurogenic oedema on the sensitized mouse ear: an in vivo study using transient receptor potential vanilloid 1 (TRPV1) receptor knockout mice.
Pozsgai G; Sándor K; Perkecz A; Szolcsányi J; Helyes Z; Brain SD; Pintér E
Inflamm Res; 2007 Nov; 56(11):459-67. PubMed ID: 18224287
[TBL] [Abstract][Full Text] [Related]
20. Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor.
Szallasi A; Blumberg PM
Life Sci; 1990; 47(16):1399-408. PubMed ID: 2174484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
